local_hospital

Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse

Address
lock Available on a paid plan

Respiratory Tract Diseases and Asthma Research

At the Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse, a large share of the clinical research focuses on respiratory tract diseases, especially asthma and chronic obstructive pulmonary disease. These studies are exploring new and improved ways to control symptoms, reduce flare-ups, and support better long-term lung function.

  • Testing innovative treatments for severe asthma, including eosinophilic and poorly controlled forms
  • Evaluating therapies aimed at reducing COPD exacerbations and improving breathing outcomes
  • Comparing inhaled treatment options to find more effective symptom control

The work in this area is designed to improve everyday disease management and help patients maintain better respiratory stability over time.

Immune System Diseases and Type 2 Inflammation

This site also contributes to research on immune system diseases, with a strong emphasis on inflammation-driven airway conditions. Many of the studies are centered on biologic therapies that target the immune pathways involved in asthma and COPD.

  • Assessing biologic medicines for eosinophilic asthma and other difficult-to-control respiratory conditions
  • Studying treatments that may lower the frequency of asthma attacks and improve disease control
  • Exploring long-term safety and benefit of immune-targeted therapies in chronic lung disease

These trials aim to refine treatment approaches for patients whose symptoms are linked to persistent airway inflammation and immune imbalance.

Virus Diseases and Infectious Respiratory Illness

Another important theme at the site is research in virus diseases, particularly conditions affecting the lungs and airways. Studies here include work on influenza and COVID-19, with a focus on finding better ways to treat infection and prevent severe outcomes.

  • Evaluating treatments for SARS-CoV-2 infection in nonhospitalized patients at risk of worsening illness
  • Investigating therapies for severe viral lung infections requiring respiratory support
  • Studying antiviral resistance and the spread of influenza virus within households

These trials are helping to improve infection management, protect vulnerable patients, and support earlier intervention when respiratory viruses become serious.

Environment and Public Health with Vaccination Studies

Research in environment and public health at this hospital includes vaccine-related studies and prevention-focused work. The site is involved in trials that look at how well vaccines protect older adults and children against common respiratory and viral threats.

  • Assessing influenza vaccines for stronger protection in older adults
  • Studying immunization strategies for children and families exposed to viral illness
  • Supporting public health efforts through prevention of seasonal and contagious infections

Overall, this research aims to strengthen disease prevention and reduce the burden of respiratory infections in the community.

Site Overview

assignment
38
connected trials
corporate_fare
20
sponsors
science
53
IMPs

Activity Indicator

Last 6 months

5
Trials started
+400% vs previous period.
1
Trials started 6–12 months ago
38
Total trials linked
Highly Active
trending_upGrowing+400%
1
1
1
1
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 4 therapeutic areas and 15 of 53 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years

Top 40 of 53 compounds, ranked by number of trials.

lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
15
Sponsors (total)
20
Active sponsors
13

Sponsor Network

Top 13 by active trials.

lock +12 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

lock +7 more on a paid plan

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 476 other sites in Bulgaria

description
Trial volume
38
Outperforms 94% of sites
public
Therapeutic diversity
4areas
Outperforms 72% of sites
groups
Sponsor diversity
20sponsors
Outperforms 92% of sites

Therapeutic Area Benchmark — Bulgaria

Select a therapeutic area to compare against other sites in Bulgaria.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Bulgaria

Market Share

Country: Bulgaria

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Specialized Hospital For Active Treatment Of Pneumo-Phthisiatric Diseases Dr. Dimitar Gramatikov-Ruse

lock Showing 1 of 38 trials — the rest is available on a paid plan.

IMP list

lock Showing 1 of 53 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Formoterol Fumarate Dihydrate6Unknown2021-04-292026-04-13

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.